Boston Scientific (BSX) Total Current Liabilities (2009 - 2026)
Boston Scientific (BSX) posted quarterly Total Current Liabilities of $6.4 billion for Q2 2026, up 23.85% year-over-year from $5.2 billion in Q2 2025, and up 40.63% on a QoQ basis from $4.6 billion in Q1 2026.
Boston Scientific (BSX) Total Current Liabilities (2009 - 2026) Analysis & Trends
Boston Scientific has reported Total Current Liabilities for 18 years, with the latest figure at $6.4 billion in Q2 2026.
- Total Current Liabilities for Q2 2026 came in at $6.4 billion, up 23.85% year-over-year; the trailing twelve-month figure through Jun 2026 was $6.4 billion (up 23.85% YoY), and the FY2025 annual result was $5.4 billion, down 15.0% from the prior year.
- Total Current Liabilities climbed to $6.4 billion in Q2 2026, from $4.6 billion in the prior quarter.
- Over five years, Total Current Liabilities peaked at $6.4 billion in Q2 2026 and troughed at $3.5 billion in Q3 2022.
- A 5-year average of $4.9 billion and a median of $4.9 billion in 2023 frame the typical range for Total Current Liabilities.
- The widest annual swing landed in 2024, when Total Current Liabilities increased 29.72%; it then slipped 15.0% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $3.8 billion in 2022, then rose by 29.71% to $4.9 billion in 2023, then advanced by 29.72% to $6.4 billion in 2024, then dropped by 15.0% to $5.4 billion in 2025, then climbed by 18.18% to $6.4 billion in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $6.4 billion in Q2 2026, $4.6 billion in Q1 2026, and $5.4 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Zimmer Biomet Holdings | 19.37 Bn | 18.96 Bn | 1.54 Bn | 3.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.43 Bn |
| Mar 31, 2026 | 4.57 Bn |
| Dec 31, 2025 | 5.44 Bn |
| Sep 30, 2025 | 5.33 Bn |
| Jun 30, 2025 | 5.19 Bn |
| Mar 31, 2025 | 5.06 Bn |
| Dec 31, 2024 | 6.40 Bn |
| Sep 30, 2024 | 5.91 Bn |
| Jun 30, 2024 | 5.58 Bn |
| Mar 31, 2024 | 4.92 Bn |
| Dec 31, 2023 | 4.93 Bn |
| Sep 30, 2023 | 4.58 Bn |
| Jun 30, 2023 | 4.56 Bn |
| Mar 31, 2023 | 4.08 Bn |
| Dec 31, 2022 | 3.80 Bn |
| Sep 30, 2022 | 3.55 Bn |
| Jun 30, 2022 | 3.88 Bn |
| Mar 31, 2022 | 4.28 Bn |
| Dec 31, 2021 | 4.27 Bn |
| Sep 30, 2021 | 4.02 Bn |